Details

Autor(en) / Beteiligte

• Raja, Deep Chandh
• Chopra, Aashish
• Subban, Vijayakumar
• Maharajan, Rashmi
• Anandhan, Harini
• Vasu, Nandhakumar
• Farook, Jawahar
• Paramasivam, Ramachandran
• Narayanan, Srinivasan
• Uthayakumaran, Kalaichelvan
• Pakshirajan, Balaji
• Victor, Suma
• Solirajaram, Ramkumar
• Krishnamoorthy, Jaishankar
• Janakiraman, Ezhilan
• Pandurangi, Ulhas M.
• Kalidoss, Latchumanadhas
• Mullasari, Ajit Sankaradas

Titel

Predictors of short-term outcomes in patients undergoing percutaneous coronary intervention in cardiogenic shock complicating STEMI—A tertiary care center experience

Ist Teil von

• Indian heart journal, 2018-12, Vol.70 (Suppl 3), p.S259-S264

Ort / Verlag

India: Elsevier B.V

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• Studying the outcomes in patients presenting with cardiogenic shock with ST-segment elevation myocardial infarction (CS-STEMI) and undergoing primary or rescue percutaneous coronary intervention (PCI) may give an insight to the unmet needs in STEMI-care in our region and may help in future recommendations in improving survival. During the period from January 2001- June 2017, there were 114 patients included in the study. The demographic, clinical and angiographic characteristics were compared between the survivors and non-survivors. All these variables were also compared between two-time frames (Phase 1- January 2001 to June 2007; Phase 2- July 2007 to June 2017). Among patients undergoing PCI for STEMI, 7.5% were in cardiogenic shock. In-hospital mortality for the patients included in the study was 53.5%. Total ischemic time (OR=0.99, 0.99–1; p=0.02), left ventricular ejection fraction (LVEF) (OR=0.90, 0.82–0.98; p=0.02), need for cardio-pulmonary resuscitation (OR=0.12, 0.24–0.66; p=0.01), and post PCI TIMI flows (OR=0.08, 0.02–0.29; p<0.001) were the significant determinants of in-hospital mortality in the regression analysis. There was no significant change in mortality between the two phases of the study, though there was a reduction in total ischemic and door-to-balloon times, transfer admissions, use of thrombolytics, glycoprotein IIb/IIIa inhibitors, intra-aortic balloon pump, and mechanical ventilation in phase 2. Patients presenting in CS-STEMI and undergoing PCI continue to experience high mortality rates, despite improvements in total ischemic times. Further improvement in the systems-of-care are required to bring about reduction in mortality in this high-risk subset.